Descripteur français |
Glycogénose de type II |
Descripteur américain |
Glycogen Storage Disease Type II |
Terme(s) français |
Glycogénose de type II /
Glycogénose de type II juvénile /
Glycogénose de type 2 juvénile /
Glycogénose de type II infantile /
Glycogénose de type 2 infantile /
Glycogénose de type II de l'adulte /
Glycogénose de type 2 de l'adulte /
|
Terme(s) américain(s) |
Glycogen Storage Disease Type II /
Glycogen Storage Disease Type II, Juvenile /
Juvenile Glycogen Storage Disease Type II /
Glycogen Storage Disease Type II, Infantile /
Infantile Glycogen Storage Disease Type II /
Acid Maltase Deficiency /
Acid Maltase Deficiencies /
Deficiencies, Acid Maltase /
Deficiency, Acid Maltase /
Maltase Deficiencies, Acid /
Alpha-1,4-Glucosidase Deficiency /
Alpha 1,4 Glucosidase Deficiency /
Alpha-1,4-Glucosidase Deficiencies /
Deficiencies, Alpha-1,4-Glucosidase /
Deficiency, Alpha-1,4-Glucosidase /
Adult Glycogen Storage Disease Type II /
Glycogen Storage Disease Type II, Adult /
|
Scope Note |
An autosomal recessively inherited glycogen storage disease caused by GLUCAN 1,4-ALPHA-GLUCOSIDASE deficiency. Large amounts
of GLYCOGEN accumulate in the LYSOSOMES of skeletal muscle (MUSCLE, SKELETAL); HEART; LIVER; SPINAL CORD; and BRAIN. Three
forms have been described: infantile, childhood, and adult. The infantile form is fatal in infancy and presents with hypotonia
and a hypertrophic cardiomyopathy (CARDIOMYOPATHY, HYPERTROPHIC). The childhood form usually presents in the second year of
life with proximal weakness and respiratory symptoms. The adult form consists of a slowly progressive proximal myopathy. (From
Muscle Nerve 1995;3:S61-9; Menkes, Textbook of Child Neurology, 5th ed, pp73-4)
|
Code(s) d'arborescence |
C10.228.140.163.100.435.340 /
C16.320.565.189.435.340 /
C16.320.565.202.449.500 /
C16.320.565.595.554.340 /
C18.452.132.100.435.340 /
C18.452.648.189.435.340 /
C18.452.648.202.449.500 /
C18.452.648.595.554.340 /
|
Qualificatifs autorisés français |
diagnostic /
parasitologie /
immunologie /
microbiologie /
imagerie diagnostique /
physiopathologie /
rééducation et réadaptation /
enzymologie /
étiologie /
mortalité /
épidémiologie /
sang /
liquide cérébrospinal /
induit chimiquement /
diétothérapie /
traitement médicamenteux /
thérapie /
psychologie /
urine /
virologie /
médecine vétérinaire /
histoire /
classification /
économie /
embryologie /
génétique /
soins infirmiers /
radiothérapie /
ethnologie /
prévention et contrôle /
anatomopathologie /
métabolisme /
complications /
chirurgie /
|
Qualificatifs autorisés américains |
diagnosis /
parasitology /
immunology /
microbiology /
diagnostic imaging /
physiopathology /
rehabilitation /
enzymology /
etiology /
mortality /
epidemiology /
blood /
cerebrospinal fluid /
chemically induced /
diet therapy /
drug therapy /
therapy /
psychology /
urine /
virology /
veterinary /
history /
classification /
economics /
embryology /
genetics /
nursing /
radiotherapy /
ethnology /
prevention & control /
pathology /
metabolism /
complications /
surgery /
|
Qualificatifs autorisés abrégés |
DI /
PS /
IM /
MI /
DG /
PP /
RH /
EN /
ET /
MO /
EP /
BL /
CF /
CI /
DH /
DT /
TH /
PX /
UR /
VI /
VE /
HI /
CL /
EC /
EM /
GE /
NU /
RT /
EH /
PC /
PA /
ME /
CO /
SU /
|
Indexation antérieure |
Glucosidases/metabolism (1966-1974) /
Glycogenosis (1966-1974) /
Heart Diseases (1966-1974) /
|
Identifiant |
D006009 |
Date d'ajout et note historique |
1989(1975); use GLYCOGENOSIS 1975-1988
|
Voir aussi le(s) descripteur(s) français |
|
Voir aussi le(s) descripteur(s) américain(s) |
Glucan 1,4-alpha-Glucosidase /
|